Clinical Trials Browser

Lung Neoplasms

NCT05117840 2026-04-03

SHIELD

Active not recruiting

12,000 enrolled

Thoracic

Lung Neoplasms

NCT06122610 2026-03-19

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

Phase 1 Recruiting

10 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT03258593 2026-03-17

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

Phase 1 Completed

15 enrolled 21 charts

Genitourinary

Urinary Bladder Neoplasms, Carcinoma in Situ

NCT07478757 2026-03-17

Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized Controlled Trial in Hong Kong

Phase NA Not yet recruiting

15,000 enrolled

Thoracic

Lung Neoplasms

NCT07462247 2026-03-12

Establishment of Image Database for Early Upper Gastrointestinal Cancer, Precancerous Lesions, and Precancerous Conditions

Recruiting

500 enrolled

Gastrointestinal

Gastrointestinal Neoplasms

NCT03151564 2026-03-05

Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques

Phase NA Active not recruiting

146 enrolled

Gastrointestinal

Colonic Neoplasms, Digestive System Diseases, Colorectal Neoplasms

NCT04857528 2026-03-04

Detecting HPV DNA in Anal and Cervical Cancers

Recruiting

20 enrolled

GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms

NCT03789240 2026-03-03

Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma

Phase 2 Active not recruiting

33 enrolled 17 charts

Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT07417488 2026-02-27

GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas

Phase 1 Not yet recruiting

18 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03388619 2026-02-23

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

Phase 1 Completed

30 enrolled 16 charts

Genitourinary

Prostatic Neoplasms

NCT07416825 2026-02-18

Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19

Phase NA Completed

23 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT04432597 2026-02-17

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

Phase 1/2 Active not recruiting

39 enrolled

GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

NCT04504331 2026-02-12

Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer

Phase 1 Terminated

4 enrolled 11 charts

Breast

Breast Neoplasms

NCT03458520 2026-02-09

Pediatric PET/MR Image Registry

Recruiting

100 enrolled

LymphoidSarcoma

Lymphoma, Osteosarcoma

NCT07383454 2026-02-03

Lung Cancer Screening in Population Who Had Never Smoked

Phase NA Not yet recruiting

2,500 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms, Small Cell Lung Carcinoma

NCT02297672 2026-02-02

PBSI

Phase NA Active not recruiting

75 enrolled

Breast

Breast Neoplasms

NCT03697577 2026-01-23

CDK and Body Composition Study

Recruiting

30 enrolled

Breast

Breast Neoplasms

NCT04294641 2026-01-23

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

Phase 2 Completed

10 enrolled 15 charts

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

NCT06865677 2026-01-21

Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas

Phase 2 Terminated

2 enrolled 7 charts

Recurrence

NCT06199713 2026-01-20

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

Recruiting

24 enrolled

Dermatologic

Melanoma

Clinical Trials

LUCAS-LATAM

SHIELD

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized Controlled Trial in Hong Kong

Establishment of Image Database for Early Upper Gastrointestinal Cancer, Precancerous Lesions, and Precancerous Conditions

Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques

Detecting HPV DNA in Anal and Cervical Cancers

Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma

GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer

Pediatric PET/MR Image Registry

Lung Cancer Screening in Population Who Had Never Smoked

PBSI

CDK and Body Composition Study

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients